CD8A and neoplasm: Via cross-presentation, these antigens are processed by antigen-presenting cells (APC) to stimulate adaptive immune responses, allowing cytotoxic CD8+ T cells (CTL) to recognize these tumor antigens in the context of MHC molecules just like foreign antigens [2].